摘要
背景:糖尿病(DM)是一种严重的内分泌代谢性疾病,并伴有各种长期并发症。然而,已经确定了过多的目标,但可能会有不利的影响。因此,研究人员一直在寻找安全和更有效的治疗方法。天然产物,特别是来自植物,已被证明通过多种机制发挥抗糖尿病作用。 方法:综述糖尿病发病机制及其微血管并发症。提供了草药治疗糖尿病管理的可能潜在机制,突出了一些关键的治疗靶点。该综述还评价了草药产品通过调节炎症和肠道微生物群治疗糖尿病的最新进展。最后,我们讨论了目前可用的药物治疗方法。 结果:结果表明,许多植物已被证明是胰岛素分泌剂、α-葡萄糖苷酶和α-淀粉酶抑制剂的良好来源。在非常规靶点中,抑制脂肪酶、胆碱酯酶和血管紧张素转换酶等关键酶已直接和/或间接地与糖尿病和糖尿病并发症有关。例如,从穿孔金丝桃中分离的金丝霉素、假金丝霉素和I3、ii8-双芹菜素,以及从金金丝桃中分离的棕榈和钴胺。W.T.Wang&P.K分别被发现是强大的脂肪酶和胆碱酯酶抑制剂。此外,据报道,许多植物衍生化合物如玉米麸、黄芩素和小檗碱的铁酰化低聚糖通过调节肠道微生物群介导抗糖尿病特性。 结论:本综述中积累的信息有望为支持天然抗糖尿病药物开发的先进研究提供有用的科学基线信息。
关键词: 糖尿病,微生物组,脂肪酶,胆碱酯酶,血管紧张素转换酶,药物。
Current Medicinal Chemistry
Title:Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications
Volume: 28 Issue: 23
关键词: 糖尿病,微生物组,脂肪酶,胆碱酯酶,血管紧张素转换酶,药物。
摘要:
Background: Diabetes Mellitus (DM) is a severe endocrine metabolic disease coupled with various long-term complications. A plethora of targets have been identified, however, with possible adverse effects. Therefore, researchers are in the perpetual quest for safe and more effective therapeutics. Natural products, particularly derived from plants, have proven to exert anti-diabetic effects via diverse mechanisms.
Methods: An overview of DM pathogenesis and its associated micro- and macro-vascular complications is presented. Possible underlying mechanisms of herbal remedies in DM management are provided, highlighting some key therapeutic targets. The review also appraises the recent progress of herbal products in treating DM through regulating inflammation and gut microbiota. Finally, currently available pharmacological treatments are discussed.
Results: The results show that numerous plants have proven to be promising sources of insulin secreting agents, α-glucosidase and α-amylase inhibitors. Among the non- conventional targets, inhibition of key enzymes such as lipase, cholinesterases and angiotensin converting enzyme has been directly and/or indirectly linked to DM and DM complications. For instance, hypericin, pseudohypericin and I3,II8-biapigenin isolated from Hypericum perforatum L., and palmatine and columbamine isolated from Dichocarpum auriculatum (Franch.) W. T. Wang & P. K have been found to be powerful lipase and cholinesterase inhibitors, respectively. Moreover, a number of plant-derived compounds such as feruloylated oligosaccharides from maize bran, baicalein and berberine are reported to mediate anti-diabetic property via modulation of gut microbiota.
Conclusion: The information amassed in this review is anticipated to provide useful scientific baseline information to support advanced research in natural antidiabetic drug development.
Export Options
About this article
Cite this article as:
Conventional and Non-Conventional Targets of Natural Products in the Management of Diabetes Mellitus and Associated Complications, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867327666201102120120
DOI https://dx.doi.org/10.2174/0929867327666201102120120 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From CHD Susceptibility Genes to New Therapeutics
Current Pharmacogenomics Device-based Therapies for Resistant Hypertension
Current Pharmaceutical Design Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Angiogenic Effects of Resveratrol on Cerebral Angiogenesis
Current Neurovascular Research Gender And Susceptibility To Sepsis Following Trauma
Endocrine, Metabolic & Immune Disorders - Drug Targets Pleiotropic Effects of PPARγ Agonist on Hemostatic Activation in Type 2 Diabetes Mellitus
Current Vascular Pharmacology Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis
Current Pharmaceutical Design Resveratrol: A Therapeutic Promise for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia
Current Pharmaceutical Design Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Conivaptan: Potential Therapeutic Implications in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Towards More Efficient Glutathione Peroxidase Mimics: Substrate Recognition and Catalytic Group Assembly
Current Medicinal Chemistry Advancement in Microsponge Drug Delivery System: Preparation Methods, Patents and Commercial Utility
Recent Patents on Drug Delivery & Formulation Fetal Origins of Cardiovascular Disease
Current Cardiology Reviews Proteomic Analysis of Liver Diseases: Molecular Mechanisms and Biomarker Discovery
Mini-Reviews in Medicinal Chemistry Targeting Lung Inflammation: Novel Therapies for the Treatment of COPD
Current Respiratory Medicine Reviews MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Towards Human on a Chip: Recent Progress and Future Perspective
Micro and Nanosystems S100A1: Structure, Function, and Therapeutic Potential
Current Chemical Biology Heart Transplantation in Biventricular Congenital Heart Disease: Indications, Techniques, and Outcomes
Current Cardiology Reviews